PVOTF

 
Ordinary Shares SEC Reporting - Current
OTCQB
Contact Info
  • 1275 West 6th Avenue
  • Vancouver, BC V6H 1A6
  • Canada

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jul 31, 2016 10-Q
CIK 0001464165
Fiscal Year End 1/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: British Columbia, Canada
Year of Inc. 2002
Employees 3 a/o Feb 24, 2011
Company Officers/Contacts
Pravin Chaturvedi CEO
Moira Ong CFO, Principal Acct. Officer
Stewart Muglich Legal Counsel
Company Directors
Ahmad Doroudian Chairman
Pravin Chaturvedi
Patrick Frankham
Wolfgang Renz
Company Notes
  • Formerly=Neurokine Pharmaceuticals Inc. until 4-2015
Service Providers
Accounting/Auditing Firm
Sadler, Gibb & Associates, LLC
2455 E. Parleys Way
Suite 320
Salt Lake City, UT, 84109
United States

Legal Counsel
Alexander Holburn Beaudin + Lang LLP
2700-700 W Georgia Street
Vancouver, BC, V7Y 1B8
Canada

Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States

PVOTF Security Details
Share Structure
Market Value1 $7,562,210 a/o Dec 09, 2016
Authorized Shares Unlimited a/o Apr 29, 2016
Outstanding Shares 75,622,100 a/o Sep 12, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 51,954,280 a/o Apr 29, 2016
Par Value Not Available
Transfer Agent(s)
ClearTrust, LLC
Shareholders
Shareholders of Record 53 a/o Apr 29, 2016
Short Selling Data
Short Interest 300 (-40%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security